Member Info for Newuncle

1.15 v 1.17 get in there you traders.....cheap init

Ice,

i ♥ your logic here

Affrm,

All getting bit to personal on here for my liking.

Play the ball, not the man

Discussion, not abuse works

Traders, OBD shares have gone on sale again, get 'em while you can at sub 1.20.......

Affrm,

I do hope so, my concern is that I don't think it's GV's own money being used to fund the deal as they are a broker to third parties who wanted to secure their energy supplies etc.

Affrm

Can you show us that the money from GV agreement has actually materialised please?

Alright Ice, I will leave you to it for a bit, have other stuff to be doing.

Fill Yer Boots

After all, it's just another blood test, just like the PSA test....that's it

Avacta AVA6000 etc are a totally different proposition that all have to go through testing cohorts that take months and months etc and then the data has to validated and so on and so on.

The 94% PSE test isn't going through anything like that, in fact it is marketed by OBD as ready to go since October last year.

Should have been the easiest sell in the world imo.

Oh no not OAP again...at least Cat did know what he meant.

I bet if that RNS was released today you would be positively foaming at the mouth with optimism etc etc

One year in, he has delivered NOTHING

At OBD, Dr Arrivo's role will be to implement effective marketing and sales strategies for the newly launched EpiSwitch® PSE prostate cancer detection test.

*****************************************************************************************************************

His specific focus will be to grow sales in the US market, where he has considerable experience of launching products.

******************************************************************************************************************

Icecool,

How much does OBD received per PSE test...come one you should know that as a minimum at least?

Also, Look at what SA what brought in to do a year ago.....read it carefully, very, very carefully....

Nearly a year in the job and has he actually delivered anything at all?

8 Nov 2023 07:00

Oxford BioDynamics strengthens commercial leadership with new SVP of Business and Corporate Development

· Appointment of industry veteran Dr Steven Arrivo as SVP business and corporate development.

· Dr Arrivo to focus on marketing, partnering and sales of the recently launched EpiSwitch Prostate Screening (PSE) test.

At OBD, Dr Arrivo's role will be to implement effective marketing and sales strategies for the newly launched EpiSwitch® PSE prostate cancer detection test. His specific focus will be to grow sales in the US market, where he has considerable experience of launching products.

Define 5 fold increase if you can, remember Burrows has a way of dressing up his comments on such things.

What Distribution Agreements....currently OBD selling just 3 PSE test a day in the USA and UK...oh come on, my local papershop has bigger turnover than that, I assume you do know the wholesale price of a PSE test don't you (I do).

Icecool,

One thing I will say in your favour is that you know the price of everything but the value of nothing

Icecool,

and you are now an expert on OBD in just two days.....🤡🤡🤡

🎣🎣🎣🎣🎣

My PC must be broke...all gone blue

Mms want to trade again 1.10 v 1.11